These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The roles of CRISPR-Cas systems in adaptive immunity and beyond. Barrangou R Curr Opin Immunol; 2015 Feb; 32():36-41. PubMed ID: 25574773 [TBL] [Abstract][Full Text] [Related]
26. Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex. Zhu X; Ye K Nucleic Acids Res; 2015 Jan; 43(2):1257-67. PubMed ID: 25541196 [TBL] [Abstract][Full Text] [Related]
27. Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6. Niewoehner O; Jinek M RNA; 2016 Mar; 22(3):318-29. PubMed ID: 26763118 [TBL] [Abstract][Full Text] [Related]
28. To acquire or resist: the complex biological effects of CRISPR-Cas systems. Bondy-Denomy J; Davidson AR Trends Microbiol; 2014 Apr; 22(4):218-25. PubMed ID: 24582529 [TBL] [Abstract][Full Text] [Related]
29. Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes. Al-Attar S; Westra ER; van der Oost J; Brouns SJ Biol Chem; 2011 Apr; 392(4):277-89. PubMed ID: 21294681 [TBL] [Abstract][Full Text] [Related]
30. Structural insights into the inactivation of CRISPR-Cas systems by diverse anti-CRISPR proteins. Zhu Y; Zhang F; Huang Z BMC Biol; 2018 Mar; 16(1):32. PubMed ID: 29554913 [TBL] [Abstract][Full Text] [Related]
31. The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR-Cas subtype III-Bv system. Behler J; Sharma K; Reimann V; Wilde A; Urlaub H; Hess WR Nat Microbiol; 2018 Mar; 3(3):367-377. PubMed ID: 29403013 [TBL] [Abstract][Full Text] [Related]
32. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems. Giovannangeli C; Concordet JP Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487 [No Abstract] [Full Text] [Related]
33. Cas6 processes tight and relaxed repeat RNA via multiple mechanisms: A hypothesis. Sefcikova J; Roth M; Yu G; Li H Bioessays; 2017 Jun; 39(6):. PubMed ID: 28493337 [TBL] [Abstract][Full Text] [Related]
34. Structures and mechanisms of CRISPR RNA-guided effector nucleases. Nishimasu H; Nureki O Curr Opin Struct Biol; 2017 Apr; 43():68-78. PubMed ID: 27912110 [TBL] [Abstract][Full Text] [Related]
35. The ring of confidence: a haloarchaeal CRISPR/Cas system. Maier LK; Stoll B; Brendel J; Fischer S; Pfeiffer F; Dyall-Smith M; Marchfelder A Biochem Soc Trans; 2013 Feb; 41(1):374-8. PubMed ID: 23356314 [TBL] [Abstract][Full Text] [Related]
37. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Wiedenheft B; van Duijn E; Bultema JB; Waghmare SP; Zhou K; Barendregt A; Westphal W; Heck AJ; Boekema EJ; Dickman MJ; Doudna JA Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10092-7. PubMed ID: 21536913 [TBL] [Abstract][Full Text] [Related]
38. Role of CRISPR/cas system in the development of bacteriophage resistance. Szczepankowska A Adv Virus Res; 2012; 82():289-338. PubMed ID: 22420856 [TBL] [Abstract][Full Text] [Related]
39. [Progress of genome engineering technology via clustered regularly interspaced short palindromic repeats--a review]. Li H; Qiu S; Song H Wei Sheng Wu Xue Bao; 2013 Oct; 53(10):1025-30. PubMed ID: 24409757 [TBL] [Abstract][Full Text] [Related]
40. CRISPR-Cas systems and RNA-guided interference. Barrangou R Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]